• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 COVID-19 大流行期间城市废水中的抗病毒药物乌米酚(阿比多尔):估计水平和转化。

Antiviral drug Umifenovir (Arbidol) in municipal wastewater during the COVID-19 pandemic: Estimated levels and transformation.

机构信息

Core Facility Center 'Arktika', Northern (Arctic) Federal University, Arkhangelsk 163002, Russian Federation.

Core Facility Center 'Arktika', Northern (Arctic) Federal University, Arkhangelsk 163002, Russian Federation.

出版信息

Sci Total Environ. 2022 Jan 20;805:150380. doi: 10.1016/j.scitotenv.2021.150380. Epub 2021 Sep 20.

DOI:10.1016/j.scitotenv.2021.150380
PMID:34818770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8451976/
Abstract

An indole derivative umifenovir (Arbidol) is one of the most widely used antiviral drugs for the prevention and treatment of COVID-19 and some other viral infections. The purpose of the present study was to shed light on the transformation processes of umifenovir in municipal wastewater, including disinfection with active chlorine, as well as to assess the levels of the antiviral drug and its metabolites entering and accumulating in natural reservoirs under conditions of the SARS-CoV-2 pandemic. The combination of high-performance liquid chromatography with electrospray ionization high-resolution mass-spectrometry and inductively coupled plasma mass spectrometry was used for tentative identification and quantification of umifenovir and its transformation products in model reaction mixtures and real samples of wastewater, river water, biological sludge and bottom sediments taken at the wastewater treatment plant in Arkhangelsk, a large cultural and industrial center at the Russian North. Laboratory experiments allowed identifying fifteen bromine-containing transformation products, forming at the initial stages of the chlorination and fourteen classic volatile and semi volatile disinfection by-products with bromoform as the dominant one. Chlorinated derivatives are only the minor disinfection by-products forming by substitution of alkylamine group in the aromatic ring. The schemes of umifenovir transformation in reactions with dissolved oxygen and sodium hypochlorite are proposed. Two established primary transformation products formed by oxidation of the thioether group to sulfoxide and elimination of thiophenol were detected in noticeable concentrations in the wastewater together with their precursor. The level of umifenovir reached 1.3 mg kg in the sludge and municipal wastewater treat contained 1 μg L of that drug, while its removal during biological wastewater treatment was about 40%. Pronounced accumulation of umifenovir and its transformation products in biological sludge and bottom sediments of natural reservoirs may be a source of the future secondary pollution of the environment.

摘要

一种吲哚衍生物乌米酚(Arbidol)是预防和治疗 COVID-19 和其他一些病毒感染最广泛使用的抗病毒药物之一。本研究的目的是阐明乌米酚在城市废水中的转化过程,包括用活性氯消毒,以及评估在 SARS-CoV-2 大流行条件下,进入和积累在天然水库中的抗病毒药物及其代谢物的水平。本研究采用高效液相色谱与电喷雾电离高分辨质谱和电感耦合等离子体质谱相结合的方法,对模型反应混合物和取自俄罗斯北部大城市阿尔汉格尔斯克市废水处理厂的废水、河水、生物污泥和底泥的实际样品中的乌米酚及其转化产物进行了推测性鉴定和定量分析。实验室实验鉴定出了十五种含溴转化产物,这些产物是在氯化的初始阶段形成的,还有十四种经典的挥发性和半挥发性消毒副产物,其中溴仿是主要产物。氯化衍生物只是在芳香环中取代烷基胺形成的次要消毒副产物。提出了乌米酚在与溶解氧和次氯酸钠反应中的转化方案。在废水中,与前体一起检测到两种已建立的主要转化产物,它们是通过硫醚基团氧化为亚砜和消除硫酚形成的,其浓度较高。污泥和城市废水中的乌米酚水平达到 1.3mg/kg,废水中含有 1μg/L 的该药物,而在生物废水处理过程中,其去除率约为 40%。乌米酚及其转化产物在天然水库的生物污泥和底泥中的明显积累可能是未来环境二次污染的来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/4c14e82cef6b/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/0fee89e3728a/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/35d15bb7ff64/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/e5f78a1671e3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/9dffc15c5d3b/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/40f7c90f63ff/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/779f6c6848d0/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/4c14e82cef6b/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/0fee89e3728a/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/35d15bb7ff64/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/e5f78a1671e3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/9dffc15c5d3b/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/40f7c90f63ff/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/779f6c6848d0/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0351/8451976/4c14e82cef6b/gr6_lrg.jpg

相似文献

1
Antiviral drug Umifenovir (Arbidol) in municipal wastewater during the COVID-19 pandemic: Estimated levels and transformation.在 COVID-19 大流行期间城市废水中的抗病毒药物乌米酚(阿比多尔):估计水平和转化。
Sci Total Environ. 2022 Jan 20;805:150380. doi: 10.1016/j.scitotenv.2021.150380. Epub 2021 Sep 20.
2
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.乌米酚韦治疗与改善 2019 冠状病毒病患者结局无关:一项回顾性研究。
Clin Microbiol Infect. 2020 Jul;26(7):917-921. doi: 10.1016/j.cmi.2020.04.026. Epub 2020 Apr 25.
3
Sunlight-induced degradation of COVID-19 antivirals arbidol in natural aquatic environments: Mechanisms, pathways and toxicity.阳光诱导下天然水环境污染中抗新冠病毒药物阿比多尔的降解:机制、途径与毒性。
J Environ Manage. 2023 Dec 1;347:119113. doi: 10.1016/j.jenvman.2023.119113. Epub 2023 Sep 26.
4
[Umifenovir and coronavirus infections: a review of research results and clinical practice].[乌米芬诺尔与冠状病毒感染:研究结果与临床实践综述]
Ter Arkh. 2020 Dec 26;92(11):91-97. doi: 10.26442/00403660.2020.11.000713.
5
Mechanistic insights into the generation and control of Cl-DBPs during wastewater sludge chlorination disinfection process.在废水污泥氯化消毒过程中产生和控制含氯消毒副产物的机理研究
Environ Int. 2022 Sep;167:107389. doi: 10.1016/j.envint.2022.107389. Epub 2022 Jul 2.
6
Toxicity Evaluation and Effect-Based Identification of Chlorine Disinfection Products of the Anti-COVID-19 Drug Chloroquine Phosphate.抗新冠病毒药物磷酸氯喹的消毒副产物氯的毒性评估和基于效应的鉴定。
Environ Sci Technol. 2023 May 30;57(21):7913-7923. doi: 10.1021/acs.est.2c08260. Epub 2023 May 15.
7
Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR).乌米芬ovir在流感和急性呼吸道病毒感染中的临床疗效(ARBITR研究)
Ter Arkh. 2019 Mar 30;91(3):56-63. doi: 10.26442/00403660.2019.03.000127.
8
Sodium hypochlorite disinfection of SARS-CoV-2 spiked in water and municipal wastewater.次氯酸钠对水中和城市废水中 SARS-CoV-2 的消毒。
Sci Total Environ. 2022 Feb 10;807(Pt 3):150766. doi: 10.1016/j.scitotenv.2021.150766. Epub 2021 Oct 8.
9
Effect of umifenovir (arbidol) standard care on clinical outcome in patients with COVID-19: a retrospective cohort study.乌苯美司(阿比多尔)联合标准治疗对 COVID-19 患者临床结局的影响:一项回顾性队列研究。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231183811. doi: 10.1177/17534666231183811.
10
Detection, transformation, and toxicity of indole-derivative nonsteroidal anti-inflammatory drugs during chlorine disinfection.吲哚衍生物非甾体抗炎药在氯消毒过程中的检测、转化和毒性。
Chemosphere. 2020 Dec;260:127579. doi: 10.1016/j.chemosphere.2020.127579. Epub 2020 Jul 11.

引用本文的文献

1
Discovery of a novel broad-spectrum inhibitor against influenza virus A.发现一种新型抗甲型流感病毒的广谱抑制剂。
Virol J. 2025 Aug 26;22(1):290. doi: 10.1186/s12985-025-02889-2.
2
Evolution of Antiviral Drug Resistance in SARS-CoV-2.新型冠状病毒(SARS-CoV-2)中抗病毒药物耐药性的演变
Viruses. 2025 May 18;17(5):722. doi: 10.3390/v17050722.
3
Mucolytic Drugs Ambroxol and Bromhexine: Transformation under Aqueous Chlorination Conditions.黏液溶解药氨溴索和溴己新在水氯化条件下的转化。

本文引用的文献

1
Predicted occurrence, ecotoxicological risk and environmentally acquired resistance of antiviral drugs associated with COVID-19 in environmental waters.预测环境水中与 COVID-19 相关的抗病毒药物的出现、生态毒理学风险和环境获得性耐药性。
Sci Total Environ. 2021 Jul 1;776:145740. doi: 10.1016/j.scitotenv.2021.145740. Epub 2021 Feb 15.
2
The find of COVID-19 vaccine: Challenges and opportunities.COVID-19 疫苗的发现:挑战与机遇。
J Infect Public Health. 2021 Mar;14(3):389-416. doi: 10.1016/j.jiph.2020.12.025. Epub 2020 Dec 30.
3
The Need for Antiviral Drugs for Pandemic Coronaviruses From a Global Health Perspective.
Int J Mol Sci. 2024 May 10;25(10):5214. doi: 10.3390/ijms25105214.
4
Monitoring of over-the-counter (OTC) and COVID-19 treatment drugs complement wastewater surveillance of SARS-CoV-2.监测非处方 (OTC) 和 COVID-19 治疗药物可补充 SARS-CoV-2 的污水监测。
J Expo Sci Environ Epidemiol. 2024 May;34(3):448-456. doi: 10.1038/s41370-023-00613-2. Epub 2023 Dec 5.
5
Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2.吲哚类化合物作为 SARS-CoV-2 的潜在药物候选物。
Molecules. 2023 Sep 13;28(18):6603. doi: 10.3390/molecules28186603.
6
Guidance document on the impact of water treatment processes on residues of active substances or their metabolites in water abstracted for the production of drinking water.关于水处理工艺对用于饮用水生产的取水口中活性物质或其代谢物残留影响的指导文件。
EFSA J. 2023 Aug 28;21(8):e08194. doi: 10.2903/j.efsa.2023.8194. eCollection 2023 Aug.
7
Stability and WBE biomarkers possibility of 17 antiviral drugs in sewage and gravity sewers.稳定性和污水重力下水道中 17 种抗病毒药物的 WBE 生物标志物可能性。
Water Res. 2023 Jun 30;238:120023. doi: 10.1016/j.watres.2023.120023. Epub 2023 Apr 30.
8
A systematic review and meta‑analysis of Arbidol therapy for acute respiratory viral infections: A potential treatment for COVID‑19.阿比多尔治疗急性呼吸道病毒感染的系统评价和荟萃分析:一种对COVID-19的潜在治疗方法。
Exp Ther Med. 2022 Oct 31;24(6):736. doi: 10.3892/etm.2022.11672. eCollection 2022 Dec.
9
Photocatalytic degradation of COVID-19 related drug arbidol hydrochloride by TiC MXene/supramolecular g-CN Schottky junction photocatalyst.TiC MXene/超分子 g-CN 肖特基结光催化剂光催化降解 COVID-19 相关药物盐酸阿比多尔。
Chemosphere. 2022 Dec;308(Pt 3):136461. doi: 10.1016/j.chemosphere.2022.136461. Epub 2022 Sep 16.
10
Effective degradation of COVID-19 related drugs by biochar-supported red mud catalyst activated persulfate process: Mechanism and pathway.生物炭负载赤泥催化剂活化过硫酸盐工艺对新冠相关药物的有效降解:机理与途径
J Clean Prod. 2022 Mar 15;340:130753. doi: 10.1016/j.jclepro.2022.130753. Epub 2022 Feb 1.
从全球健康视角看大流行冠状病毒对抗病毒药物的需求
Front Med (Lausanne). 2020 Dec 22;7:596587. doi: 10.3389/fmed.2020.596587. eCollection 2020.
4
Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.乌米酚韦治疗 2019 年冠状病毒病(COVID-19)的疗效和安全性:系统评价和荟萃分析。
J Med Virol. 2021 Jan;93(1):481-490. doi: 10.1002/jmv.26256. Epub 2020 Jul 14.
5
Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals.阿比多尔预防卫生专业人员 COVID-19 的有效性。
Front Public Health. 2020 May 29;8:249. doi: 10.3389/fpubh.2020.00249. eCollection 2020.
6
Photolytic and photocatalytic degradation of doxazosin in aqueous solution.水溶液中多沙唑嗪的光解和光催化降解。
Sci Total Environ. 2020 Oct 20;740:140131. doi: 10.1016/j.scitotenv.2020.140131. Epub 2020 Jun 12.
7
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro.抗流感病毒药物阿比朵尔在体外是严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的有效抑制剂。
Cell Discov. 2020 May 2;6:28. doi: 10.1038/s41421-020-0169-8. eCollection 2020.
8
Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein.阿比多尔:通过阻断刺突糖蛋白三聚化治疗 SARS-CoV-2 的一种有潜力的抗病毒药物。
Int J Antimicrob Agents. 2020 Aug;56(2):105998. doi: 10.1016/j.ijantimicag.2020.105998. Epub 2020 Apr 28.
9
Antioxidant Potential of Antiviral Drug Umifenovir.抗病毒药物乌米酚的抗氧化潜力。
Molecules. 2020 Mar 30;25(7):1577. doi: 10.3390/molecules25071577.
10
Water Analysis: Emerging Contaminants and Current Issues.水分析:新出现的污染物及当前问题
Anal Chem. 2020 Jan 7;92(1):473-505. doi: 10.1021/acs.analchem.9b05269. Epub 2019 Dec 11.